New prostate cancer medication could offer hope for those with aggressive disease
There may be a “promising new strategy” in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia investigated how the novel drug, CDKI-73, has the potential to tackle drug-resistant prostate cancer. This drug reportedly “defies conventional therapies,” as noted in the study findings, … Read more